2.Employment among multiple sclerosis patients in Hong Kong
Kwok-Kwong Lau ; Alexander YL Lau ; Ellen LM Yu ; Kam-Mei Lau ; Alma Au ; Iris Chan ; Wing-Chi Fong ; Tak-Hon Tsoi ; Ping-Wing Ng ; Patrick CK Li
Neurology Asia 2016;21(2):161-167
Objective: Employment is important for patients with chronic illness, and to remain employed is a
robust support to them. This study aimed to examine the employment rate and to identify factors
associated with employment among multiple sclerosis (MS) in Hong Kong.
Methods: A cross-sectional study was performed from 2010 to 2011 at five major public hospitals.
Fifty-nine clinical definite MS patients with no evidence of dementia (Mini-Mental State Examination
≥ 22) were recruited. Demographic data and neuropsychological test results including memory, visual
perception, psychological well-being, motor, executive domain and processing speed were collected.
Principal component analysis and logistic regression with multiple imputation were used in data
analyses. Results: The employment rate among MS patients was 56%. Patients with better cognitive
functions were more likely to be employed (p=0.002). No significant association was found between
employment status and age, gender, level of education, types of MS, disease duration, frequency of
relapse or use of interferon.
Conclusion: MS patients had high unemployment rate (44%) which was 11.5 times higher than the
general population in Hong Kong. MS patients with better cognitive functions had higher employment
rates.
Multiple Sclerosis
3.Expression and Significance of BLIMP-1 in Regulatory T Cells of Children with Aplastic Anemia.
Li-Fen HUANG ; Jun-Bin HUANG ; Nan-Nan TANG ; Hong-Man XUE ; Cheng-Ming ZHU ; Chi-Kwong LI ; Chun CHEN
Journal of Experimental Hematology 2021;29(4):1251-1256
OBJECTIVE:
To study the expression of B lymphocyte-induced mature protein-1 (BLIMP-1) in regulatory T cells (Tregs) of children with aplastic anemia (AA), and analyze its correlation with the number of Tregs and the levels of inhibitory cytokines interleukin (IL)-10 and transforming growth factor (TGF)-β in plasma.
METHODS:
The peripheral blood samples of 10 newly diagnosed AA children and 10 healthy children were collected for experiment. qPCR was used to detect FOXP3 and PRDM1 mRNA expression levels. Flow cytometry was used to detect the proportion of Tregs, the expression of BLIMP-1 in Tregs, and the levels of cytokines such as IL-2, IL-17A, IL-6, interferon (IFN)-γ, IL-10 and TGF-β in plasma. Pearson correlation model was used to evaluate the relationship between the expression of BLIMP-1 in Treg and the number of Tregs, as well as the levels of IL-10 and TGF-β in plasma.
RESULTS:
Compared with control group, the proportion of Tregs in peripheral blood of AA children was decreased significantly (P<0.001); The plasma levels of proinflammatory cytokines IL-2, IL-6 and IFN-γ in AA children were increased significantly (P=0.033, P=0.031, P=0.006), and IL-17A also was increased but the difference was not statistically significant (P=0.052), while anti-inflammatory cytokines IL-10 and TGF-β were significantly reduced (P=0.048, P=0.002). The relative expressions level of FOXP3 and PRDM1 mRNA in AA children were significantly lower than those in control group (P=0.037, P=0.016). The expression of BLIMP-1 protein in Tregs of AA children was significantly lower than that in control group (P<0.001). The expression level of BLIMP-1 protein in Tregs was positively correlated with the percentage of Tregs in lymphocytes (r=0.671, P=0.001), and was also positively correlated with the levels of IL-10 and TGF-β in plasma (r=0.500, P=0.029; r=0.486, P=0.030).
CONCLUSION
The expression of BLIMP-1 in Tregs of AA children is impaired, and the low expression of BLIMP-1 is related to the decrease of the number in Tregs and IL-10 and TGF-β expressions.
Anemia, Aplastic
;
Child
;
Cytokines
;
Flow Cytometry
;
Forkhead Transcription Factors
;
Humans
;
Positive Regulatory Domain I-Binding Factor 1
;
T-Lymphocytes, Regulatory
;
Transforming Growth Factor beta
4.Construction of Nalm6-Cas9 Cell Line for Genome-Wide Translocation Sequencing.
Qing-Cheng LI ; Jun-Bing HUANG ; Hong-Man XUE ; Mo YANG ; Cheng-Ming ZHU ; Chi-Kwong LI ; Jun-Chao DONG ; Chun CHEN
Journal of Experimental Hematology 2022;30(5):1384-1390
OBJECTIVE:
In order to conduct high-throughput genome-wide translocation sequencing based on CRISPR/Cas9, Nalm6-cas9 monoclonal cell line expressing Cas9 protein was constructed by lentivirus transduction.
METHODS:
Lentiviral vectors LentiCas9-Blast, pSPAX2, and pMD2.G were used to co-transfect HEK293T cells to obtain recombinant lentivirus. After Nalm6 cells were infected with the recombinant lentivirus, the cells were screened by Blasticidin, and multiple monoclonal cell lines expressing Cas9 protein were obtained by limited dilution. Western blot was used to detect the expression level of Cas9 protein in monoclonal cell lines, and cell count analysis was used to detect the proliferation activity of monoclonal cell lines. LentiCRISPRV2GFP-Δcas9, LentiCRISPRV2GFP-Δcas9-AF4, LentiCRISPRV2GFP-Δ cas9-MLL plasmids were constructed, and transfected with pSPAX2 and pMD2.G, respectively. T vector cloning was used to detect the function of Cas9 protein in Nalm6-Cas9 monoclonal cell line infected with virus.
RESULTS:
Western blot showed that Nalm6-Cas9_1-6 monoclonal cell line had high expression of Cas9 protein. Cell count analysis showed that high expression of Cas9 protein in Nalm6-Cas9_1-6 monoclonal cell line did not affect cell proliferation activity. The Nalm6-Cas9_1-6 monoclonal cell line had high cleavage activity, and the editing efficiency of AF4 and MLL genes was more than 90% which was determined by T vector cloning.
CONCLUSION
Nalm6-Cas9_1-6 monoclonal cell line stably expressing highly active Cas9 protein was obtained, which provided a basis for exploring the translocation of MLL in therapy-related leukemias based on CRISPR/Cas9 genome-wide high-throughput genome-wide translocation sequencing.
CRISPR-Associated Protein 9/genetics*
;
CRISPR-Cas Systems
;
Genetic Vectors
;
HEK293 Cells
;
Humans
;
Lentivirus/genetics*
;
Plasmids